| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2025-09-30 | 1.23% | -53.05% | 173.33% | 91/138 | 0.51% | 惠泰医疗 | 22.41% | 行业排名> |
| 2025-06-30 | 0.45% | 21.62% | -30.77% | 93/138 | 1.91% | 惠泰医疗 | 15.03% | 行业排名> |
| 2025-03-31 | 0.65% | -35% | -10.96% | 86/138 | 1.06% | 迈瑞医疗 | 7.06% | 行业排名> |
| 2024-12-31 | 0.73% | -28.43% | -72.14% | 92/138 | 3.05% | 迈瑞医疗 | 31.95% | 行业排名> |
| 2024-09-30 | 2.62% | -1.5% | 608.11% | 81/138 | 4.75% | 迈瑞医疗 | 28.68% | 行业排名> |
| 2024-06-30 | 0.37% | -79.44% | -63% | 95/138 | 2.98% | 迈瑞医疗 | 20.2% | 行业排名> |
| 2024-03-31 | 1% | 7.53% | -1.96% | 75/138 | 1.65% | 迈瑞医疗 | 9.12% | 行业排名> |
| 2023-12-31 | 1.02% | -98.64% | -61.65% | 96/138 | 4.92% | 迈瑞医疗 | 33.21% | 行业排名> |
| 2023-09-30 | 2.66% | -96.55% | 47.78% | 89/138 | 5.8% | 迈瑞医疗 | 28.34% | 行业排名> |
| 2023-06-30 | 1.8% | -97.45% | 93.55% | 86/138 | 3.8% | 迈瑞医疗 | 18.36% | 行业排名> |
| 2023-03-31 | 0.93% | -98.63% | -98.76% | 88/138 | 2.28% | 安杰思 | 8.56% | 行业排名> |
| 2022-12-31 | 74.78% | 30.62% | -3.08% | 3/138 | 12.93% | 九安医疗 | 146.56% | 行业排名> |
| 2022-09-30 | 77.16% | 162.27% | 9.34% | 3/138 | 12.7% | 九安医疗 | 140.94% | 行业排名> |
| 2022-06-30 | 70.57% | 221.36% | 3.96% | 2/138 | 9.24% | 九安医疗 | 142.25% | 行业排名> |
| 2022-03-31 | 67.88% | 2% | 18.57% | 2/138 | 6.21% | 九安医疗 | 142.71% | 行业排名> |
| 2021-12-31 | 57.25% | -56.8% | 94.6% | 7/138 | 17.28% | 热景生物 | 121.78% | 行业排名> |
| 2021-09-30 | 29.42% | 2% | 33.97% | 12/138 | 15.82% | 热景生物 | 99.69% | 行业排名> |
| 2021-06-30 | 21.96% | -68.11% | -83.43% | 10/138 | 11.46% | 热景生物 | 99.09% | 行业排名> |
| 2020-12-31 | 132.52% | 236.26% | 92.42% | 4/138 | 25.47% | 热景生物 | 57.63% | 行业排名> |
| 2020-06-30 | 68.87% | 2% | 74.75% | 6/138 | 15.03% | 中红医疗 | 168% | 行业排名> |
| 2019-12-31 | 39.41% | -19.09% | -19.09% | 4/138 | 14.24% | 圣湘生物 | 112.46% | 行业排名> |
| 2018-12-31 | 48.71% | -17.75% | -17.75% | 1/138 | 12.87% | 博拓生物 | 108.13% | 行业排名> |
| 2017-12-31 | 59.22% | 2% | 2% | 1/138 | 13.76% | 圣湘生物 | 29.33% | 行业排名> |

微信公众号
证券之星APP


